Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in IFRX — InflaRx N.V.

CIK 19617 NEW YORK, NY
Back to IFRX Full portfolio

Position in IFRX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$7,217
+$6,918 QoQ
Shares Held
3,222
+861.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 62 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IFRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. IFRX ranks #341 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in IFRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,217 3,222
2026-03-31 $299 335
2024-12-31 $2,613 1,058
2024-09-30 $88 58
2024-06-30 $100 58
2023-12-31 $1,051 645
2023-09-30 $99,234 33,300
2023-06-30 $230,216 51,618
2023-03-31 $139,142 71,723
2022-12-31 $30,255 9,760
2022-09-30 $319 121
2022-03-31 $984 538
2021-12-31 $4,721 992
2021-09-30 $1,577 609
2020-12-31 $86,516 17,200